BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jul 7, 2017
Product Development

One small CETP for Merck

Why Merck’s anacetrapib needs to hit at least 10% risk reduction in REVEAL
BioCentury | Feb 22, 2016
Clinical News

Vytorin regulatory update

BioCentury | Feb 22, 2016
Clinical News

Zetia ezetimibe regulatory update

BioCentury | Nov 16, 2015
Clinical News

Vytorin ezetimibe/simvastatin regulatory update

BioCentury | Nov 16, 2015
Clinical News

Zetia ezetimibe regulatory update

BioCentury | Nov 11, 2015
Company News

FDA panel to discuss IMPROVE-IT data

BioCentury | Sep 14, 2015
Clinical News

Vytorin ezetimibe/simvastatin regulatory update

Items per page:
1 - 10 of 77